Latest Financial Position News

NeuroScientific Biopharmaceuticals has initiated critical IND-enabling studies for its glaucoma drug candidate EmtinB, backed by a solid cash position of A$4.5 million as of December 2024. Preliminary melanin binding results are shaping the path toward first-in-human trials.

Strickland Metals has reported exceptional drilling results from its Rogozna Project in Serbia and Yandal Project in Western Australia, alongside a robust financial footing to support ongoing exploration.

Lanthanein Resources has completed initial drilling phases at its Lady Grey Project and secured a six-month extension on its farm-in agreement, positioning the company for a critical assessment of its gold exploration prospects.

Mach7 Technologies has initiated a A$5 million on-market share buy-back program, reflecting confidence in its robust financial health and growth outlook. The move underscores the company’s commitment to capital management amid reaffirmed FY25 revenue growth guidance.

Titan Minerals reports standout drilling results at its Dynasty Gold Project’s Iguana prospect, confirming resource growth potential with significant gold and silver intercepts. The company is advancing its 10,000m drilling campaign backed by a strong balance sheet.

Patronus Resources reports significant drilling progress across its Western Australia and Northern Territory projects, with strong assay results at Mertondale and a robust cash position supporting ongoing exploration.

Lotus Resources has fast-tracked the restart of its Kayelekera uranium project in Malawi, targeting production by Q3 2025, backed by a $132 million capital raise. Meanwhile, its Letlhakane project in Botswana reports a 65% increase in measured and indicated uranium resources.

OD6 Metals reports a transformative quarter with the acquisition of the historic Gulf Creek Copper Project revealing high-grade copper assays, alongside promising metallurgical advances at its Splinter Rock rare earths project. The company enters 2025 with strong cash reserves and active exploration programs.

Imagion Biosystems has secured a AU$3 million capital injection and resumed its collaboration with Siemens, setting the stage to prioritize FDA filings and advance its MagSense® HER2 breast cancer imaging program.

Austral Gold reported an 8.5% production increase in Q4 2024 alongside significant cost reductions, though full-year output fell short of forecasts due to equipment delays. The company sets ambitious 2025 targets, supported by a new toll processing deal and plant refurbishment financing.

AusQuest Limited has announced a significant porphyry copper-gold discovery at its Cangallo Project in Peru, marking a potential turning point ahead of an active 2025 exploration calendar. The company also secured $2.4 million in funding to advance drilling programs across its Peru and Australian assets.

Buxton Resources reports robust drilling results at its Graphite Bull and Narryer projects, completes Stage 1 earn-in on Copper Wolf JV with IGO, and undertakes key board changes, positioning itself for an active 2025 exploration season.